Stenström M - Search Results

1

Paquinimod reduces skin fibrosis in tight skin 1 mice, an experimental model of systemic sclerosis.

Stenström M, Nyhlén HC, Törngren M, Liberg D, Sparre B, Tuvesson H, Eriksson H, Leanderson T. Stenström M, et al. J Dermatol Sci. 2016 Jul;83(1):52-9. doi: 10.1016/j.jdermsci.2016.04.006. Epub 2016 Apr 19. J Dermatol Sci. 2016. PMID: 27156795 Free article.

2

CD11b+Ly6C++Ly6G- cells show distinct function in mice with chronic inflammation or tumor burden.

Källberg E, Stenström M, Liberg D, Ivars F, Leanderson T. Källberg E, et al. Among authors: stenstrom m. BMC Immunol. 2012 Dec 12;13:69. doi: 10.1186/1471-2172-13-69. BMC Immunol. 2012. PMID: 23234398 Free PMC article.

3

Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides.

Björk P, Björk A, Vogl T, Stenström M, Liberg D, Olsson A, Roth J, Ivars F, Leanderson T. Björk P, et al. Among authors: stenstrom m. PLoS Biol. 2009 Apr 28;7(4):e97. doi: 10.1371/journal.pbio.1000097. PLoS Biol. 2009. PMID: 19402754 Free PMC article.

4

Selective depletion of splenic CD4 dendritic cells in mice treated with immunomodulatory quinoline-3-carboxamide ABR-215757.

Stenström M, Anderson P, Eroukhmanoff L, Leanderson T, Ivars F. Stenström M, et al. Int Immunopharmacol. 2010 Aug;10(8):837-42. doi: 10.1016/j.intimp.2010.04.011. Epub 2010 Apr 25. Int Immunopharmacol. 2010. PMID: 20423734

5

Specific effect of immunomodulatory quinoline-3-carboxamide ABR-215757 in GM-CSF stimulated bone marrow cell cultures: block of initiation of proliferation of Gr-1+ cells.

Helmersson S, Stenström M, Leanderson T, Ivars F. Helmersson S, et al. Among authors: stenstrom m. Int Immunopharmacol. 2011 Aug;11(8):1045-51. doi: 10.1016/j.intimp.2011.02.025. Epub 2011 Mar 6. Int Immunopharmacol. 2011. PMID: 21388612

6

Protein synthesis of the pro-inflammatory S100A8/A9 complex in plasmacytoid dendritic cells and cell surface S100A8/A9 on leukocyte subpopulations in systemic lupus erythematosus.

Lood C, Stenström M, Tydén H, Gullstrand B, Källberg E, Leanderson T, Truedsson L, Sturfelt G, Ivars F, Bengtsson AA. Lood C, et al. Among authors: stenstrom m. Arthritis Res Ther. 2011 Apr 14;13(2):R60. doi: 10.1186/ar3314. Arthritis Res Ther. 2011. PMID: 21492422 Free PMC article.

7

Natural killer T-cell populations in C57BL/6 and NK1.1 congenic BALB.NK mice-a novel thymic subset defined in BALB.NK mice.

Stenström M, Sköld M, Andersson A, Cardell SL. Stenström M, et al. Immunology. 2005 Mar;114(3):336-45. doi: 10.1111/j.1365-2567.2004.02111.x. Immunology. 2005. PMID: 15720435 Free PMC article.

8

MHC-dependent and -independent modulation of endogenous Ly49 receptors on NK1.1+ T lymphocytes directed by T-cell receptor type.

Sköld M, Stenström M, Sidobre S, Höglund P, Kronenberg M, Cardell S. Sköld M, et al. Among authors: stenstrom m. Immunology. 2003 Nov;110(3):313-21. doi: 10.1046/j.1365-2567.2003.01741.x. Immunology. 2003. PMID: 14632658 Free PMC article.

9

Surface receptors identify mouse NK1.1+ T cell subsets distinguished by function and T cell receptor type.

Stenström M, Sköld M, Ericsson A, Beaudoin L, Sidobre S, Kronenberg M, Lehuen A, Cardell S. Stenström M, et al. Eur J Immunol. 2004 Jan;34(1):56-65. doi: 10.1002/eji.200323963. Eur J Immunol. 2004. PMID: 14971030 Free article.

10

Molecular profiling reveals distinct functional attributes of CD1d-restricted natural killer (NK) T cell subsets.

Rolf J, Berntman E, Stenström M, Smith EM, Månsson R, Stenstad H, Yamagata T, Agace W, Sigvardsson M, Cardell SL. Rolf J, et al. Among authors: stenstrom m. Mol Immunol. 2008 May;45(9):2607-20. doi: 10.1016/j.molimm.2007.12.022. Epub 2008 Mar 4. Mol Immunol. 2008. PMID: 18304639

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

142 results

Search Page